Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

2.2K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.2K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

1.3K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.3K
Neural Regulation01:37

Neural Regulation

43.8K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
43.8K
Brainstem01:19

Brainstem

7.1K
The brainstem, located inferior to the brain and superior to the spinal cord, serves as a bridge between the cerebrum and the spinal cord. It plays a vital role in relaying information and controlling critical life functions. It comprises three primary regions: the midbrain, pons, and medulla oblongata.
The Midbrain
The midbrain is located beneath the diencephalon and connects the cerebrum with the lower parts of the brain. The cerebral peduncles are prominent midbrain structures that house the...
7.1K
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

4.7K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Distinct Transcriptional and Migratory Programs Are Associated with Vasculogenic Mimicry Heterogeneity in Triple-Negative Breast Cancer.

Cancers·2026
Same author

Combined Hormonal Contraception with Low-Dose Ethinylestradiol is Associated with Modest Reduction of Breast Milk Volume when Administered Vaginally, but Not Orally.

Breastfeeding medicine : the official journal of the Academy of Breastfeeding Medicine·2026
Same author

Novel Selective Anticancer Effect of Epididymis-Derived Extracellular Vesicles Against HCC38 and MCF-7 Breast Cancer Cell Lines.

International journal of molecular sciences·2026
Same author

Honey, We Shrunk the Mice! The Maximal Electroshock Model Goes In Vitro.

Epilepsy currents·2026
Same author

The Impact of Obesity on Operative Outcomes and Long-Term Oncological Outcomes Following Rectal Cancer Surgery: A Retrospective Single-Center Study.

Journal of clinical medicine·2026
Same author

Induction of cytochrome P450 2C9 and P-glycoprotein activity by antiseizure medications: A systematic review and network meta-analysis.

Epileptic disorders : international epilepsy journal with videotape·2026

Related Experiment Video

Updated: Feb 27, 2026

The Use of Primary Human Fibroblasts for Monitoring Mitochondrial Phenotypes in the Field of Parkinson's Disease
15:09

The Use of Primary Human Fibroblasts for Monitoring Mitochondrial Phenotypes in the Field of Parkinson's Disease

Published on: October 3, 2012

17.4K

Consensus Molecules Associated with Parkinson's Disease.

Sara Eyal1, Shira Alfasi1, Karin Ben Zaken1

  • 1Azrieli Faculty of Medicine, Bar Ilan University, Safed 1311502, Israel.

Neurology International
|February 26, 2026
PubMed
Summary
This summary is machine-generated.

This study analyzed the Human Metabolome Database to find associations between Parkinson's disease (PD) and various compounds. It identified numerous drugs, biomarkers, and chemical inducers linked to PD, offering new research directions.

Keywords:
Parkinson’s diseasecoenzyme Q10cofactorstetrahydrobiopterinvitamins

More Related Videos

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
08:09

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease

Published on: January 7, 2014

8.0K
Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
06:07

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease

Published on: June 23, 2023

2.3K

Related Experiment Videos

Last Updated: Feb 27, 2026

The Use of Primary Human Fibroblasts for Monitoring Mitochondrial Phenotypes in the Field of Parkinson's Disease
15:09

The Use of Primary Human Fibroblasts for Monitoring Mitochondrial Phenotypes in the Field of Parkinson's Disease

Published on: October 3, 2012

17.4K
Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
08:09

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease

Published on: January 7, 2014

8.0K
Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
06:07

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease

Published on: June 23, 2023

2.3K

Area of Science:

  • * Metabolomics and Neurodegenerative Diseases
  • * Pharmacology and Toxicology
  • * Biochemistry of Neurodegeneration

Background:

  • * Parkinson's disease (PD) is a complex neurodegenerative disorder.
  • * Existing research suggests potential links between PD and environmental factors, including specific foods and drugs.
  • * A comprehensive understanding of these associations is crucial for developing effective prevention and treatment strategies.

Purpose of the Study:

  • * To systematically investigate the associations between Parkinson's disease and a wide range of chemical compounds.
  • * To leverage the Human Metabolome Database (HMDB) and PubMed for a large-scale co-citation analysis.
  • * To identify specific drugs, biomarkers, and endogenous molecules associated with PD.

Main Methods:

  • * Utilized a comprehensive list of 217,776 compounds from the Human Metabolome Database (HMDB).
  • * Developed a Python script to query PubMed for co-citations between Parkinson's disease (PD) and each compound.
  • * Adjusted co-citation counts based on compound abundance to refine association strength.

Main Results:

  • * Identified significant associations between PD and various compound categories: small-molecule drugs, adjunctive therapies, contraindicated drugs, diagnostic agents, biomarkers, conditional essential molecules, and inducers.
  • * Highlighted specific drugs like L-dopa, carbidopa, entacapone, rasagiline, ropinirole, and pramipexole with high association percentages.
  • * Confirmed known PD inducers such as 6-hydroxydopamine (6-OHDA), MPTP, and rotenone, and identified others like salsolinol and BMAA.

Conclusions:

  • * This study provides a data-driven overview of compounds associated with Parkinson's disease.
  • * The findings underscore the importance of specific drugs and endogenous molecules in PD pathogenesis and progression.
  • * Highlights conditional essential endogenous cofactors and suggests rational directions for future PD research.